LEHI, Utah , Sept. 3, 2024 /PRNewswire/ — Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for inflammatory and neurodegenerative diseases, today announced a pivotal strategic collaboration with Southern…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
